Actavis Chairman Joins Zoetis Board Under Deal With Activist Investor Ackman
Pfizer spinoff Zoetis, the animal health company, added a second director to its board under a deal it reached earlier this year with activist investor Bill Ackman and his firm Pershing Square Capital Management...
Related Articles
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- The CIO-Plus Of Vivint Smart Home Named To The Board Of Domo also categorized in BoardMoves
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Why Do Board Directors And CEOs Need To Value UN Sustainability Goal 5 ? - Achieve Gender Equality And Empower All Women And Girls also categorized in BoardMoves
- The Future Of Clean Beauty Is Female: Maureen Chiquet, Former Global CEO Of Chanel, Joins Credo Board Of Directors also categorized in BoardMoves
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- Hewlett-Packard Shakes Up Management, Raises Outlook also mentions Management
Login to comment.